|
|
|
|
| LEADER |
02808nam a22004935i 4500 |
| 001 |
978-3-319-09414-4 |
| 003 |
DE-He213 |
| 005 |
20151204171632.0 |
| 007 |
cr nn 008mamaa |
| 008 |
140915s2014 gw | s |||| 0|eng d |
| 020 |
|
|
|a 9783319094144
|9 978-3-319-09414-4
|
| 024 |
7 |
|
|a 10.1007/978-3-319-09414-4
|2 doi
|
| 040 |
|
|
|d GrThAP
|
| 050 |
|
4 |
|a RC261-271
|
| 072 |
|
7 |
|a MJCL
|2 bicssc
|
| 072 |
|
7 |
|a MED062000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 614.5999
|2 23
|
| 100 |
1 |
|
|a Aravalli, Rajagopal N.
|e author.
|
| 245 |
1 |
0 |
|a Hepatocellular Carcinoma
|h [electronic resource] :
|b Cellular and Molecular Mechanisms and Novel Therapeutic Strategies /
|c by Rajagopal N. Aravalli, Clifford J. Steer.
|
| 264 |
|
1 |
|a Cham :
|b Springer International Publishing :
|b Imprint: Springer,
|c 2014.
|
| 300 |
|
|
|a VI, 69 p. 2 illus. in color.
|b online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 347 |
|
|
|a text file
|b PDF
|2 rda
|
| 490 |
1 |
|
|a SpringerBriefs in Cancer Research
|
| 505 |
0 |
|
|a Introduction -- Etiology -- Current diagnosis and treatment options for HCC -- Pathophysiology of HCC -- Molecular mechanisms of HCC -- Animal models of liver cancer -- Novel therapeutic strategies to combat HCC -- Conclusions.
|
| 520 |
|
|
|a This book provides up-to-date information on the development and progression of hepatocellular carcinoma (HCC) with a review of the cellular and molecular mechanisms involved in the disease process. Recent research in HCC has led to significant progress in our understanding of the cellular processes and molecular mechanisms that occur during multi-stage events that lead to hepatocarcinogenesis. The emergence of micro RNAs and molecular targeted therapies have added a new dimension in our efforts to combat this deadly disease, Chapters include discussion and evaluation of current intervention strategies and therapeutic options and a focus on the novel approaches that are being pursued, such as micro-RNA based therapies and personalized medicine to treat liver cancer. This book will be of interest to basic and clinical researchers, as well as to drug developers.
|
| 650 |
|
0 |
|a Medicine.
|
| 650 |
|
0 |
|a Cancer research.
|
| 650 |
|
0 |
|a Pharmaceutical technology.
|
| 650 |
|
0 |
|a Oncology.
|
| 650 |
1 |
4 |
|a Biomedicine.
|
| 650 |
2 |
4 |
|a Cancer Research.
|
| 650 |
2 |
4 |
|a Oncology.
|
| 650 |
2 |
4 |
|a Pharmaceutical Sciences/Technology.
|
| 700 |
1 |
|
|a Steer, Clifford J.
|e author.
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer eBooks
|
| 776 |
0 |
8 |
|i Printed edition:
|z 9783319094137
|
| 830 |
|
0 |
|a SpringerBriefs in Cancer Research
|
| 856 |
4 |
0 |
|u http://dx.doi.org/10.1007/978-3-319-09414-4
|z Full Text via HEAL-Link
|
| 912 |
|
|
|a ZDB-2-SBL
|
| 950 |
|
|
|a Biomedical and Life Sciences (Springer-11642)
|
